Piper Sandler raises Glaukos stock target to $180, keeps overweight
Piper Sandler analyst Matt O'Brien increased the price target for Glaukos Corporation (NYSE:GKOS) shares to $180 from the previous target of $140, while maintaining an Overweight rating on the stock.
Food and Drug Administration wants to put nutrition labels front and center on food products
The U.S. Food and Drug Administration wants to put nutrition information front and center on food products to give consumers ...
PipelineReview.com3d
Antennova Presents Latest Phase I/II Data on ATN-022 in Advanced/Metastatic Gastric Cancer, Including an ORR of 42.9%, at ASCO GI 2025
BOSTON, MA, USA I1, 2025 I Antennova, a clinical-stage biotech company focused on oncology today announced the presentation of latest data from ...
Popular First Aid Beauty moisturizer recalled by FDA
The FDA says about 2,756 jars of First Aid Beauty Ultra Repair Cream Coconut Vanilla are being recalled due to a deviation from Current Good Manufacturing Practice regulations, which regulates quality ...
FDA bans Red 3 dye from food and drugs – a scientist explains the artificial color’s health risks and long history
Over 35 years after the first study linking Red 3 to thyroid cancer in rats was published, the US is beginning to wean it out ...
Trump Administration Orders a Temporary Freeze on Food and Health Agency Communications
Dr. Dorothy Fink, the acting secretary for the Department of Health and Human Services under President Donald Trump, has ...